Eugenie Reich represents whistleblowers of fraud in science, technology, healthcare, and the pharmaceutical industry.  

Eugenie joined Pollock Cohen LLP after spending three years as a core member of the team that recovered $900 million in a False Claims Act kickback lawsuit against Biogen—a record for a case prosecuted by a law firm without government intervention. Eugenie’s primary role in this epic case was to gain command of the best evidence for fraud, drawn from more than 1.5 million documents produced over a ten-year period. She also collaborated with experts to enable estimates of the number of prescriptions written by doctors that the company had likely bribed through sham consulting or speaker payments. The case settled the day after Eugenie and three colleagues argued motions at the final pretrial hearing in federal district court.

Eugenie has more than 20 years of experience investigating scientific fraud, initially as a highly-regarded investigative science journalist. She is the author of Plastic Fantastic: How the Biggest Fraud in Physics Shook the Scientific World (Palgrave Macmillan, 2009), which recounts physicist Jan Hendrik Schön’s time at Bell Laboratories (“Bell Labs”) in 2002. Based on interviews with Schön’s colleagues, co-authors, and whistleblowers, the book describes how the financial pressure of the dot-com collapse on the telecommunications company that owned Bell Labs, combined with perverse publication incentives in the scientific community, enabled Schön to perpetrate this major case of fraud. Eugenie also documented the havoc that Schön’s false claims wreaked on the lives of early career researchers assigned the thankless task of replicating his fabricated experiments.

In addition to whistleblowers, Eugenie has also represented patients and their families harmed by dangerous medical devices. She served as part of a team that obtained favorable settlements for the families of two women who died after their uterine cancers were upstaged by doctors’ use of morcellators to conduct laparoscopic hysterectomies. In such cases, she seeks not only compensation for patients and their families, but also to drive industry reform. 

From 2000 to 2014, Eugenie published bylined articles reporting on developments in physics and other scientific fields for media outlets that included New Scientist, Nature, Scientific American, The Boston Globe, and Slate. She has published investigative articles exposing fraudulent or reckless claims by researchers at leading research institutions, and she has sued the United States under the Freedom of Information Act.

Eugenie is licensed to practice in the Commonwealth of Massachusetts and admitted in the federal District of Massachusetts and the District of the District of Columbia. She holds a J.D. from Boston University School of Law and a B.A. in Physics and Philosophy from Oxford University in the U.K.

Matters

  • Representing the family of a low-income patient of a federally qualified health center who died after receiving substandard care.
  • Consulting for New England Innocence Project to assist with representation of prisoners wrongfully convicted as a result of flawed forensic science.
  • Consulting for litigation finance company on viability of investment in qui tam matter.
  • Assisted the Commonwealth of Massachusetts in its pre-filing consumer fraud investigation of opioid manufacturers and distributors.
  • Assisted the United States in its investigation of scientific fraud in the stem cell laboratory of Piero Anversa at Brigham & Women's Hospital in Boston, including summarizing evidence for knowing use of flawed protocols, misleading record-keeping, and photoshopped images, as well as researching the problem of quantifying the government's damages in cases of academic grant fraud.
  • Suing, as a reporter, the United States pro se, and later with contingent fee representation, in order to obtain a report of investigation into an alleged scientific fraud case at a national laboratory.

Note: This list may include matters completed prior to joining Pollock Cohen LLP.